Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist and intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers non-dialysis products, including acute cardiopulmonary and apheresis products. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2017, it operated 3,752 outpatient dialysis clinics in approximately 50 countries. The company has operations in Germany, the United States, and internationally. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
SymbolNYSE:FMS
CUSIPN/A
Phone49-6172-6090
Debt
Debt-to-Equity Ratio0.53
Current Ratio1.26
Quick Ratio1.01
Price-To-Earnings
Trailing P/E Ratio22.64
Forward P/E Ratio19.34
P/E Growth2.85
Sales & Book Value
Annual Sales$20.09 billion
Price / Sales1.52
Cash Flow$3.5755 per share
Price / Cash13.90
Book Value$19.97 per share
Price / Book2.49
Profitability
EPS (Most Recent Fiscal Year)$2.21
Net Income$1.45 billion
Net Margins7.29%
Return on Equity11.09%
Return on Assets4.92%
Miscellaneous
Employees114,000
Outstanding Shares612,900,000
Market Cap$30,455.20
